Denmark· DK-28106367419
Bemrist Breezhaler
A indacaterol und mometason product containing indacaterolacetat, mometasonfuroat, registered in Denmark by Novartis Europharm Limited. The same ATC class is registered in 11 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Indacaterol und mometason is registered in 11 of 19 countries.
Countries holding a registration under ATC R03AK14 (indacaterol und mometason), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 7 of them publish a price we can compare per daily dose
Indacaterol und mometason · ATC R03AK14
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
Price per daily dose
What a daily dose of indacaterol und mometason costs, country by country.
Normalised to the WHO defined daily dose (0.15 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Indacaterol und mometason · price per daily dose (0.15 mg)
USD · FX 28 Sept 2026
- CH Switzerland$1.85
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- Indacaterolacetat, Mometasonfuroat
- Manufacturer
- Novartis Europharm Limited
- Country
- Denmark (DK)
- ATC code
- R03AK14
- ATC class
- Indacaterol und Mometason
- Defined daily dose
- 0.15 mg, Inhal
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28106367419
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under R03AK14
Indacaterol und mometason, as other registers publish it.
- IcelandAtectura BreezhalerNovartis Europharm Limited*
- PolandAtectura BreezhalerNovartis Europharm Limited
- NorwayAtectura BreezhalerNovartis Europharm Limited (1)
- FinlandAtectura BreezhalerNovartis Europharm Limited
- PolandAtectura BreezhalerNovartis Europharm Limited
- FinlandAtectura BreezhalerNovartis Europharm Limited
- FinlandAtectura BreezhalerNovartis Europharm Limited
- IcelandAtectura BreezhalerNovartis Europharm Limited*
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e8d37022-f7f0-4e95-829f-d6116c645b65 GET /v1/drugs/e8d37022-f7f0-4e95-829f-d6116c645b65?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "inhalationspulver, hård kapsel",
"source": "dkma",
"strength": "125+62,5 mikrogram",
"auth_role": "MOD",
"dk_drugid": "28106367419",
"substance": "Indacaterolacetat, Mometasonfuroat",
"auth_procedure": "Central",
"in_medicinpriser": false,
"registration_date_serial": "43984"
}See everything about indacaterol und mometason.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.